Biofilm: The pathogenesis of slime glycocalyx

Orthopaedic Nursing

Volumn 27, Issue 6, 2008, Pages 361-369

  Childs, Sharon G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349216814     PISSN: 07446020     EISSN: 1542538X     Source Type: Journal    
DOI: 10.1097/01.NOR.0000342424.51960.ce     Document Type: Article

References (46)

1. Abraham, W. R. (2006). Controlling biofilms of gram-positive pathogenic bacteria. Current Medicine and Chemistry, 13(13), 1509-1524.
2. Ammendolia, M. G., DiRosa, R., Montanaro, L., Arciola, C. R., & Baldassarri, L. (1999). Slime production and expression of the slime-associated antigen of staphylococcal clinical isolates. Journal of Clinical Microbiology, 37(10), 3235-3238.
3. Arciola, C. R., Campoccia, D., Gamberini, S., Donati, M. E., Baldassarri, L. & Montanaro, L. (2003). Occurrence of ica genes for slime synthesis in a collection of Staphylococcus epidermidis strains from orthopedic infections. Acta Orthopaedica Scandinavica, 74(5), 617-621.
4. Bai, K. Y., Li, Y. H., Tang, H., Von Schroeder. H., & Cvitkovitch, D. G. (2002). 2848 Biofilm formation by me-thicillin-resistant Staphylococcus aureus on orthopaedic screws. Retrieved September 17, 2007, from http:// iadr.confex.com/iadr/2002SanDiego/techprogram/abstract-13202.htm
5. Brown, E., Wenzel, R. P., & Hendley, J. O. (1989). Explanation of the microbial anatomy of normal human skin by using plasmid profiles of coagulase-negative Staphylococcus: Search for the reservoir of resident skin flora. Journal of Infectious Disease, 160, 644-650.
6. Chaignon, P., Sadovskaya, I., Ragunah, C. H., Ramasubbu, N., Kaplan, J. B., & Jabbouri, S. (2007). Susceptibility of staphylococcal biofilms to enzymatic treatment depends on their chemical composition. Applied Microbiology and Biotechnology, 75(1), 125-132.
7. Costerton, J. W. (2005). Biofilm theory can guide the treatment of device-related orthopaedic infections. Clinical Orthopaedics and Related Research, 437, 7-11.
8. Costerton, S. W., Stewart, P. S., & Greenberg, E. P. (1999). Bacterial biofilms: A common cause of persistent infections. Science, 284(5418), 1387-1392.
9. Donlan, R. M. (2001). Biofilms and device-associated infections. Emerging Infectious Disease, 7(2), 1-10.
10. Curvale, G., & Raoult, D. (1993). Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrobial Agents and Chemotherapy, 37(6), 1214-1218.
11. Duggan, J. M., Georgiadis, G. M., & Kleshinski, J. F. (2001). Management of prosthetic joint infections. Infectious Medicine, 18(12), 534-541.
12. Ehrlich, G. D., Stoodley, P., Kathju, S., Zhao, Y., McLeod, B. R., Balaban, N., et al. (2005). Engineering approaches for the detection and control of orthopaedic biofilm infections. Clinical Orthopaedics and Related Research, 437, 59-66.
13. Geipel, U., & Herrmann, M. (2005). The infected implant: Bacteriology. Unfallchirurg, 108(11), 961-977.
14. Goldenberg, D. L., & Sexton, D. J. (2007a). Pathogenesis, clinical manifestations, and diagnosis of prosthetic joint infections. Retrieved July 18, 2007, from http://patients/ uptodate.com/topic.asp?fileskin-inf/ 6751&titleBiofilms
15. Goldenberg, D. L., & Sexton, D. J. (2007b). Treatment of prosthetic joint infections. Retrieved July 18, 2007, from http://patients.uptodate.com/ topic.asp?fileskin-inf/ 7167
16. Gotz, F. (2002). Staphylococcus and biofilms. Molecular Microbiology, 43, 1367-1378.
17. Gristina, A. G., & Costerton, J. W. (1985). Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. Journal of Bone and Joint Surgery (American volume), 67, 264-273.
18. Gustilo, R. B., Gruninger, R. P. L., & Tsukayama, D. T. (1989). Orthopaedic infection. Philadelphia: WB Saunders.
19. Hendley, J. O., & Ashe, K. M. (1991). Effect of topical antimicrobial treatment on aerobic bacteria in the stratum corneum of human skin. Antimicrobial Agents and Chemotherapy, 35, 627-663.
20. Hussain, M., Wilcox, M. H., & White, P. J. (1993). The slime of coagulase-negative staphylococcus: Biochemistry and relation to adherence. FEMS Microbiology Review, 10, 191-207. (Pubitemid 223031403)
21. Irlam, J. (2004). Thwarting biofilms. The National Journal of Technology Commercialization, 10-11, 31-32.
22. Ichiman, I., & Yoshida, K. (1981). The relationship of capsular type Staphylococcus epidermidis to virulence and induction of resistance in the mouse. Journal of Applied Bacteriology, 51, 229-241.
23. Joint, I., Downie, J. A., & Williams. P. (2007). Bacterial conversations: Talking listening and eavesdropping. An introduction. Philosophical Transactions of the Royal Society, 362, 1115-1117.
24. Kang-Birken, S. L. (2000). Comparative in vitro activity of vancomycin and levofloxacin in combination with rifampin against planktonic versus sessile cells of Staphylococcus epidermidis. Pharmacotherapy, 20(6), 673-678.
25. Kaya, D., Agartan, C. A., & Yucel, M. (2007). Agents as a cause of surgical wound infections: An overview of host factors. Wounds, 19(8), 218-222.
26. Kloos, W. E., & Bannerman, T. E. (1994). Update on clinical significance of coagulase-negative staphylococci. Clinical Microbiology Reviews, 7, 117-140.
27. Kumar, A., & Prasad, R. (2006). Biofilms. JK Science, 8(1), 14-17.
28. Lewandowski, Z. (2000). Structure and function of biofilms. In L. Evans (Ed), Biofilms: Recent advances in their study and control (pp. 1-17). Amsterdam: Howard Academic Publishers.
29. Naderi, S., Acar, F., & Mertol, T. (2003). Is spinal instrumentation a risk factor for late-onset infection in cases of distant infection or surgery? Neurosurgery Focus, 15(3), 1-6.
30. Nelson, C. L., McLaren, A. C., McLaren, S. G., Johnson, J. W., & Smeltzer, M. S. (2005). Is aseptic loosening truly aseptic? Clinical Orthopaedics and Related Research, 437, 25-30.
31. Nikel, J. C., & McLean, R. J. (1998). Bacterial biofilms in urology. Infections in Urology, 11(6), 169-175.
32. Parsek, M. R., & Greenberg, E. P. (2005). Sociomicrobiology: The connections between quorum sensing and biofilms. Trends in Microbiology, 13(1), 27-33.
33. Pickering, S. A., Bayston, R., & Scammell, B. E. (2003). Electromagnetic augmentation of antibiotic efficacy in infected orthopaedic implants. Journal of Bone and Joint Surgery (British volume), 85(4), 588-593.
34. Purevdorj, B., & Stoodley, P. (2003). The role of cell signaling in biofilm development. In P. Lens, V. O'Flaherty, A. Moran, P. Stoodley, & T. Mahony (Eds.), Biofilms in industry, medicine, and environmental biotechnology: Characteristics, analysis, and control (pp. 63-78). London: IWA Publishing.
35. Ryder, M. A. (2005). Catheter-related infections: It's all about biofilm. Topics in Advanced Practice Nursing e Journal, 5(3).1-15. Retrieved August 13, 2007, from http://www.medscape.com/viewarticle/508109-print
36. Sadovskaya, I., Chaignon, P., Kogan, G., Chokr, A., Vinogradov, E., & Jabbouri, S. (2006). Carbohydrate-containing components of biofilms produced in vitro by some staphylococcal strains related to orthopaedic prosthesis infections. FEMS Immunology Medicine and Microbiology, 47(1), 75-82.
37. Sadovskaya, I., Vinogradov, E., Flahaut, S., Kogan, G., & Jabbouri, S. (2005). Extracellular carbohydrate-containing polymers of a model biofilm-producing strain, Staphylococcus epidermidis RP62A. Infection and Immunity, 37(5), 3007-3017.
38. Sheehan, E., McKenna, J., Dowling, D., & McCormack, D. (2001). Plasma enhanced deposition of anti-bacterial silver coatings on stainless steel orthopaedic implants. European Cells and Materials, 1(S2), 75.
39. Stoodley, P., Hall-Stoodley, L., Boyle, F., Jorgensen, F., & Lappin-Scott, H. M. (2000). Environmental and genetic factors influencing biofilm structure. In D. Allison, P. Gilbert, H. Lappin-Scott, & M. Wilson (Eds), Community structure and cooperation in biofilms (pp. 53-64). Cambridge, England: Cambridge University Press.
40. Stoodley, P., Kathju, S., Hu, F. Z., Erdos, G., Levenson, J. E., Mehta, N., et al. (2005). Molecular and imaging techniques for bacterial biofilms in arthroplasty infections. Clinical Orthopaedics and Related Research, 437, 31-40.
41. Trampuz, A., & Zimmerli, W. (2006). Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment. Drugs, 66(8), 1089-1105.
42. van de Belt, H., Neut, D., Schenk, W., van Horn, J., van der., Mei, H. C., et al. (2001). Infection of orthopedic implants and the use of antibiotic-loaded bone cements. Acta Orthopaedica Scandinavica, 72(6), 557-571.
43. Ward, J. P., King, J. R., Koerber, A. J., Croft, J. M., Sockett, R. E., & Williams, P. (2003). Early development and quorum sensing in bacterial biofilms. Journal of Math and Biology, 47(1), 23-55.
44. West, S. A., Griffin, A. S., Gardner, A., & Diggle, S. P. (2006). Social evolution theory for microorganisms. Nature Reviews and Microbiology, 4(8), 597-6-7.
45. Whitehouse, J. D., & Sexton, D. J. (2006). Epidemiology and pathogenesis of and risk factors for surgical site infection. Retrieved July 18, 2007, from http://patients. uptodate.com/print.asp?printtrue&fileskin-inf/ 13186
46. Zimmerli, W., Widmer, A. F., Blatter, M., Frei, R., & Ochsner, P. E. (1998). Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: A randomized controlled trial. Journal of the American Medical Association, 279(19), 1537-1541.